Haemonetics Corporation is a global provider of blood and plasma supplies and services, and acquires the Cdn. medical device manufacturer to bolster its lineup.
Haemonetics Corporation entered into a definitive agreement to acquire Opsens Inc. for approximately CAD 340 million on October 10, 2023. Haemonetics will acquire all outstanding shares of OpSens.
OPSENS RECEIVES FINAL ORDER FOR ARRANGEMENT WITH HAEMONETICS tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Haemonetics to Present at 42nd Annual J P Morgan Healthcare Conference kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.
Haemonetics Co. (NYSE:HAE – Get Free Report) was the target of a large increase in short interest during the month of November. As of November 15th, there was short interest totalling 1,800,000 shares, an increase of 7.1% from the October 31st total of 1,680,000 shares. Based on an average daily trading volume, of 276,000 shares, […]